Resistance To Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways (Resistance To Targeted Anti-Cancer Therapeutics, 15)

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.

• | Author: Yosef Yarden, Moshe Elkabets
• | Publisher: Springer
• | Publication Date: Feb 02, 2019
• | Number of Pages: 262 pages
• | Language: English
• | Binding: Paperback
• | ISBN-10: 3030098176
• | ISBN-13: 9783030098179